• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经针芯活检诊断为不确定恶性潜能的乳腺病变(B3)或疑似恶性的乳腺病变(B4)的结果,包括上皮非典型性的详细评估。

Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.

机构信息

Department of Histopathology, Nottingham University Hospitals, City Hospital Campus, Nottingham, UK.

出版信息

Histopathology. 2011 Mar;58(4):626-32. doi: 10.1111/j.1365-2559.2011.03786.x. Epub 2011 Mar 3.

DOI:10.1111/j.1365-2559.2011.03786.x
PMID:21371081
Abstract

AIMS

To provide updated evidence of the outcome of breast lesions of uncertain malignant potential (B3) and suspicious of malignancy (B4) diagnosed on needle core biopsy (NCB) and analyse the outcome of the different types of intraductal epithelial atypia.

METHODS AND RESULTS

One-hundred and forty-nine B3 and 26 B4 NCBs diagnosed over a 2-year period (2007-2008) were compared with those diagnosed over a previous 2-year period (1998-2000). The proportion of B3 diagnoses increased from 3.1% to 4.5%, and the positive predictive value (PPV) of malignancy of a B3 core decreased from 25% to 10%. Increased diagnosis of radial scar and reductions in the PPV of lobular neoplasia and of atypical intraductal proliferation may explain the reduction in the PPV of the B3 group as a whole. There were no significant changes in the proportion of B4 diagnosis (1.1% and 0.8%) or the PPV of B4 (83% and 88%). Review of cores with intraductal atypia showed a wide range of PPVs, from 100% for suspicious of ductal carcinoma in situ, to 40% for atypical ductal hyperplasia categorized as B3, and 14% for isolated flat epithelial atypia.

CONCLUSION

The study has found a decrease in the PPV for a B3 diagnosis and suggests possible explanations.

摘要

目的

提供关于经皮穿刺活检(NCB)诊断的不确定恶性潜能的乳腺病变(B3)和疑似恶性病变(B4)的结果的最新证据,并分析不同类型的导管上皮不典型增生的结果。

方法和结果

比较了在 2 年期间(2007-2008 年)诊断的 149 例 B3 和 26 例 B4 NCB 与在之前 2 年期间(1998-2000 年)诊断的病例。B3 诊断的比例从 3.1%增加到 4.5%,B3 核心的恶性肿瘤阳性预测值(PPV)从 25%降低到 10%。增加的放射状瘢痕的诊断以及小叶肿瘤和非典型导管增生的 PPV 的降低可能解释了整个 B3 组 PPV 的降低。B4 诊断的比例(1.1%和 0.8%)或 B4 的 PPV(83%和 88%)没有显著变化。对有导管上皮不典型的核心进行复查显示,PPV 范围很广,从可疑导管原位癌的 100%到归类为 B3 的非典型导管增生的 40%,以及孤立的扁平上皮不典型增生的 14%。

结论

该研究发现 B3 诊断的 PPV 降低,并提出了可能的解释。

相似文献

1
Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.经针芯活检诊断为不确定恶性潜能的乳腺病变(B3)或疑似恶性的乳腺病变(B4)的结果,包括上皮非典型性的详细评估。
Histopathology. 2011 Mar;58(4):626-32. doi: 10.1111/j.1365-2559.2011.03786.x. Epub 2011 Mar 3.
2
Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.粗针活检确定的“恶性潜能不确定”和“怀疑恶性”乳腺病变的预测价值
Ann Surg Oncol. 2007 Feb;14(2):704-11. doi: 10.1245/s10434-006-9212-8. Epub 2006 Dec 7.
3
Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.乳腺钼靶筛查发现的异常中,针芯活检对具有不确定恶性潜能病变(B3)诊断的预测价值
Histopathology. 2008 Dec;53(6):650-7. doi: 10.1111/j.1365-2559.2008.03158.x.
4
Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy.乳腺B3病变中无上皮异型性与恶性肿瘤风险降低相关。
Breast. 2017 Feb;31:144-149. doi: 10.1016/j.breast.2016.11.007. Epub 2016 Nov 17.
5
Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.乳腺 X 线筛查异常中经乳腺针芯活检诊断为不确定恶性潜能病变(B3)的特征和转归。
Int J Cancer. 2011 Sep 15;129(6):1417-24. doi: 10.1002/ijc.25801. Epub 2011 Feb 11.
6
Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).乳腺粗针穿刺活检报告为可疑恶性(B4)或恶性潜能不确定病变(B3)患者的切除活检结果。
Histopathology. 2003 Apr;42(4):331-6. doi: 10.1046/j.1365-2559.2003.01582.x.
7
Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.B3 型筛查性病变经针芯活检与切除组织学检查的相关性:Merrion 乳腺筛查单位的经验。
J Clin Pathol. 2009 Dec;62(12):1136-40. doi: 10.1136/jcp.2009.067280.
8
Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.针芯活检能够可靠地区分乳腺的良性和恶性乳头状病变。
Histopathology. 2005 Mar;46(3):320-7. doi: 10.1111/j.1365-2559.2005.02082.x.
9
Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.乳腺 X 线筛查中发现的“性质不明的恶性潜能”病变(B3)。
BMC Cancer. 2018 Aug 16;18(1):829. doi: 10.1186/s12885-018-4742-6.
10
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential.恶性潜能不确定的B3型乳腺病变存在异质性风险特征。
Tumori. 2020 Apr;106(2):115-125. doi: 10.1177/0300891619868301. Epub 2019 Aug 27.

引用本文的文献

1
Vacuum-Assisted Excision of B3 Lesions: A District General Hospital Experience.B3 病变的真空辅助切除术:一家地区综合医院的经验
Indian J Radiol Imaging. 2024 Dec 31;35(2):326-331. doi: 10.1055/s-0044-1801267. eCollection 2025 Apr.
2
Vacuum-assisted excision: a safe minimally invasive option for benign phyllodes tumor diagnosis and treatment-a systematic review and meta-analysis.真空辅助切除:一种用于乳腺叶状肿瘤诊断和治疗的安全微创选择——系统评价与Meta分析
Front Oncol. 2024 May 14;14:1394116. doi: 10.3389/fonc.2024.1394116. eCollection 2024.
3
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection.
真空辅助活检后未进行后续手术切除的高危乳腺病变的长期随访
Breast Care (Basel). 2024 Feb;19(1):62-72. doi: 10.1159/000533673. Epub 2023 Sep 7.
4
Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England.在乳房筛查期间发现非典型性病变,随后发生癌症:英格兰斯隆非典型性前瞻性队列的观察性分析。
BMJ. 2024 Feb 1;384:e077039. doi: 10.1136/bmj-2023-077039.
5
B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies.超声或乳腺X线引导下真空辅助乳腺活检中的B3病变:3634例连续活检的单中心经验
Cancers (Basel). 2021 Oct 29;13(21):5443. doi: 10.3390/cancers13215443.
6
Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy.经皮真空辅助切除(VAE)对不确定恶性潜能(B3 病变)的乳腺病变的有效性,可作为开放性手术活检的替代方法。
Eur Radiol. 2021 Dec;31(12):9540-9547. doi: 10.1007/s00330-021-08060-z. Epub 2021 Jun 8.
7
Apparent diffusion coefficient values in borderline breast lesions upgraded and not upgraded at definitive histopathological examination after surgical excision.手术切除后经最终组织病理学检查升级和未升级的乳腺交界性病变中的表观扩散系数值
Pol J Radiol. 2021 Apr 30;86:e255-e261. doi: 10.5114/pjr.2021.105857. eCollection 2021.
8
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?在真空辅助活检 (VAB) 诊断为不确定恶性潜能 (B3) 的乳腺病变中,恶性的阳性预测值:是否仍建议手术切除?
Eur Radiol. 2021 Feb;31(2):920-927. doi: 10.1007/s00330-020-07161-5. Epub 2020 Aug 20.
9
External Validation of a Risk Stratification Score for B3 Breast Lesions Detected at Ultrasound Core Needle Biopsy.超声引导下粗针穿刺活检发现的B3级乳腺病变风险分层评分的外部验证
Diagnostics (Basel). 2020 Mar 26;10(4):181. doi: 10.3390/diagnostics10040181.
10
Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens.非典型导管增生及低估风险:组织取样方法、多灶性和相关钙化显著影响基于后续手术标本的诊断升级率。
Breast Cancer. 2019 Jul;26(4):452-458. doi: 10.1007/s12282-018-00943-2. Epub 2018 Dec 27.